SCHEMBL3386789

SCHEMBL3386789

Cc1ccc(C(N)CCO)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
MAOA P21397 2/20 0.39
MAOB P27338 1/20 0.39
CA7 P43166 1/20 0.39
CHRNA7 P36544 1/20 0.37
ACHE P22303 2/20 0.36
SLC6A4 P31645 1/20 0.35
SLC2A1 P11166 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
ESR2 Q92731 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.34
GBA1 P04062 1/20 0.34
KIF11 P52732 3/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
ANPEP P15144 1/20 0.33
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14782317 1.00 ALOX5 (0.40) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL28713370 0.82 CYP1A2 (0.44) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL17619269 0.82 CHRNA7 (0.39) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL3636547 0.82 CHRNA7 (0.39) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL12195403 0.82 CHRNA7 (0.39) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL10194399 0.80 GRM8 (0.37) SLC6A4SLC2A1MAPTTDP1GBA1
SCHEMBL29172465 0.80 SLC2A1 (0.43) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL12056799 0.80 SLC2A1 (0.43) ALOX5MAOAMAOBCA7CHRNA7
SCHEMBL6572701 0.80 TAAR1 (0.45) KDM4EMAPTESR2TDP1LMNA
Hydrochloric Acid SCHEMBL4784094 0.80 CHRNA7 (0.38) ALOX5MAOAMAOBCA7CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022131741-A1 ISOXAZOLIDINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2022-06-23 WO disclosed
EP-3160943-B1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2019-09-18 EP disclosed
CN-103930407-B Aminopyrimidine derivatives useful as modulators of kinase activity 默克专利有限公司 2019-02-26 CN disclosed
EP-3160943-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO Dow AgroSciences LLC (US) 2017-05-03 EP disclosed
US-9326516-B2 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto DOW AGROSCIENCES LLC (US) 2016-05-03 US disclosed
WO-2015200175-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2015-12-30 WO disclosed
US-20150366204-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2015-12-24 US disclosed
US-8415480-B2 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor MERCK SERONO SA (CH) 2013-04-09 US disclosed
EP-1487442-B1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR MERCK SERONO SA (CH) 2010-12-01 EP disclosed
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2009-08-27 US disclosed
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR LABORATOIRES SERONO S.A. (CH) 2008-10-16 US disclosed
US-20050215605-A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor MERCK SERONO SA (CH) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366204-A1 MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO ACHE, DDT, MLYCD ALOX5 1208/4885MAOA 680/4885MAOB 871/4885
US-20090215749-A9 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 ALOX5 105/4885MAOA 2395/4885MAOB 2113/4885
US-20080255094-A1 THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR PTGER4, PTGER2, PTGER1 ALOX5 105/4885MAOA 2395/4885MAOB 2113/4885
US-20050215605-A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor TBXA2R, CNR2, PTGDR ALOX5 90/4885MAOA 1550/4885MAOB 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.